These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36100153)

  • 1. Untargeted approach to investigating the metabolomics profile of type 2 diabetes emiratis.
    Banimfreg BH; Shamayleh A; Alshraideh H; Semreen MH; Soares NC
    J Proteomics; 2022 Oct; 269():104718. PubMed ID: 36100153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Untargeted metabolomic profiling reveals molecular signatures associated with type 2 diabetes in Nigerians.
    Doumatey AP; Shriner D; Zhou J; Lei L; Chen G; Oluwasola-Taiwo O; Nkem S; Ogundeji A; Adebamowo SN; Bentley AR; Gouveia MH; Meeks KAC; Adebamowo CA; Adeyemo AA; Rotimi CN
    Genome Med; 2024 Mar; 16(1):38. PubMed ID: 38444015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Untargeted Metabolomic Plasma Profiling of Emirati Dialysis Patients with Diabetes versus Non-Diabetic: A Pilot Study.
    Banimfreg BH; Alshraideh H; Shamayleh A; Guella A; Semreen MH; Al Bataineh MT; Soares NC
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-diagnostic biomarkers of type 2 diabetes identified in the UAE's obese national population using targeted metabolomics.
    Fikri AM; Smyth R; Kumar V; Al-Abadla Z; Abusnana S; Munday MR
    Sci Rep; 2020 Oct; 10(1):17616. PubMed ID: 33077739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined intake of glucose-and lipid-lowering medications further elevates plasma levels of PCSK9 in type 2 diabetes patients.
    Awadallah S; Taneera J; Mohammed AK; Unnikannan H; Sulaiman N
    Diabetes Metab Syndr; 2020; 14(6):2087-2092. PubMed ID: 33142230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-targeted metabolomic biomarkers and metabotypes of type 2 diabetes: A cross-sectional study of PREDIMED trial participants.
    Urpi-Sarda M; Almanza-Aguilera E; Llorach R; Vázquez-Fresno R; Estruch R; Corella D; Sorli JV; Carmona F; Sanchez-Pla A; Salas-Salvadó J; Andres-Lacueva C
    Diabetes Metab; 2019 Apr; 45(2):167-174. PubMed ID: 29555466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers for obese and non-obese Type 2 diabetes identified using whole blood metabolomics.
    Teruya T; Sunagawa S; Mori A; Masuzaki H; Yanagida M
    Sci Rep; 2023 Feb; 13(1):2460. PubMed ID: 36774491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can miR-145-5p be used as a marker in diabetic patients?
    Shahrokhi SZ; Saeidi L; Sadatamini M; Jafarzadeh M; Rahimipour A; Kazerouni F
    Arch Physiol Biochem; 2022 Oct; 128(5):1175-1180. PubMed ID: 32412315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults.
    Qiu G; Zheng Y; Wang H; Sun J; Ma H; Xiao Y; Li Y; Yuan Y; Yang H; Li X; Min X; Zhang C; Xu C; Jiang Y; Zhang X; He M; Yang M; Hu Z; Tang H; Shen H; Hu FB; Pan A; Wu T
    Int J Epidemiol; 2016 Oct; 45(5):1507-1516. PubMed ID: 27694567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acyl ethanolamides in Diabetes and Diabetic Nephropathy: Novel targets from untargeted plasma metabolomic profiles of South Asian Indian men.
    Devi S; Nongkhlaw B; Limesh M; Pasanna RM; Thomas T; Kuriyan R; Kurpad AV; Mukhopadhyay A
    Sci Rep; 2019 Dec; 9(1):18117. PubMed ID: 31792390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased circulating butyrate and ursodeoxycholate during probiotic intervention in humans with type 2 diabetes.
    McMurdie PJ; Stoeva MK; Justice N; Nemchek M; Sieber CMK; Tyagi S; Gines J; Skennerton CT; Souza M; Kolterman O; Eid J
    BMC Microbiol; 2022 Jan; 22(1):19. PubMed ID: 34996347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CMap analysis identifies Atractyloside as a potential drug candidate for type 2 diabetes based on integration of metabolomics and transcriptomics.
    Li H; Shi X; Jiang H; Kang J; Yu M; Li Q; Yu K; Chen Z; Pan H; Chen W
    J Cell Mol Med; 2020 Jul; 24(13):7417-7426. PubMed ID: 32469143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics and Lipidomics Analyses Aid Model Classification of Type 2 Diabetes in Non-Human Primates.
    Tao P; Conarello S; Wyche TP; Zhang NR; Chng K; Kang J; Sana TR
    Metabolites; 2024 Mar; 14(3):. PubMed ID: 38535319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Untargeted serum metabolomics and tryptophan metabolism profiling in type 2 diabetic patients with diabetic glomerulopathy.
    Zhang F; Guo R; Cui W; Wang L; Xiao J; Shang J; Zhao Z
    Ren Fail; 2021 Dec; 43(1):980-992. PubMed ID: 34157945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indolepropionic acid and novel lipid metabolites are associated with a lower risk of type 2 diabetes in the Finnish Diabetes Prevention Study.
    de Mello VD; Paananen J; Lindström J; Lankinen MA; Shi L; Kuusisto J; Pihlajamäki J; Auriola S; Lehtonen M; Rolandsson O; Bergdahl IA; Nordin E; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Landberg R; Eriksson JG; Tuomilehto J; Hanhineva K; Uusitupa M
    Sci Rep; 2017 Apr; 7():46337. PubMed ID: 28397877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomics of Type 1 and Type 2 Diabetes.
    Arneth B; Arneth R; Shams M
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31109071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Untargeted metabolomic profiling identifies serum metabolites associated with type 2 diabetes in a cross-sectional study of the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.
    Liu Y; Gan L; Zhao B; Yu K; Wang Y; Männistö S; Weinstein SJ; Huang J; Albanes D
    Am J Physiol Endocrinol Metab; 2023 Feb; 324(2):E167-E175. PubMed ID: 36516224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomics profiles associated with HbA1c levels in patients with type 2 diabetes.
    Yun JH; Lee HS; Yu HY; Kim YJ; Jeon HJ; Oh T; Kim BJ; Choi HJ; Kim JM
    PLoS One; 2019; 14(11):e0224274. PubMed ID: 31697702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomic comparison followed by cross-validation of enzyme-linked immunosorbent assay to reveal potential biomarkers of diabetic retinopathy in Chinese with type 2 diabetes.
    Wang Z; Tang J; Jin E; Ren C; Li S; Zhang L; Zhong Y; Cao Y; Wang J; Zhou W; Zhao M; Huang L; Qu J
    Front Endocrinol (Lausanne); 2022; 13():986303. PubMed ID: 36157454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Hydroxyhexanoic Acid Predicts Early Renal Functional Decline in Type 2 Diabetes Patients with Microalbuminuria.
    Tang X; You J; Liu D; Xia M; He L; Liu H
    Kidney Blood Press Res; 2019; 44(2):245-263. PubMed ID: 31071709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.